HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Cosmetics Relocation Should Be Priority To Eliminate Distraction – CTFA

This article was originally published in The Rose Sheet

Executive Summary

Delaying the move of FDA's Office of Cosmetics & Colors from two temporary facilities to one main office is hindering progress on the office's top program priorities, the Cosmetic, Toiletry and Fragrance Association asserts in comments to the Center for Food Safety & Applied Nutrition Aug. 4

You may also be interested in...



CTFA To Seek Clarity On Wrinkle Product Regulatory Status, BSE Rule

The Cosmetic, Toiletry and Fragrance Association will likely submit a legal memorandum to FDA later this month supporting exclusion of wrinkle removers containing alpha hydroxy and beta hydroxy acids from OTC review, according to President Ed Kavanaugh

CTFA To Seek Clarity On Wrinkle Product Regulatory Status, BSE Rule

The Cosmetic, Toiletry and Fragrance Association will likely submit a legal memorandum to FDA later this month supporting exclusion of wrinkle removers containing alpha hydroxy and beta hydroxy acids from OTC review, according to President Ed Kavanaugh

Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results

FDA's draft guidance for labeling of alpha hydroxy acid-containing products is an interim step taken while the agency continues to evaluate AHAs and their impact on increased skin sensitivity to the sun, FDA says in a Dec. 2 1Federal Register notice

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel